Key Considerations For A Successful EU Orphan Drug Launch
Source: Almac Group
During this interactive webinar, the speakers involved will utilize their experience to guide you through the EU product launch process, from submitting your Marketing Application (MA) to final distribution of drug product to the end-user.
By watching you will gain insight into:
- The European regulatory framework.
- The importance of the role of a Qualified Person (QP) and European market release requirements.
- Key European packaging considerations (Regionalization, Blue Box, Serialization).
- Supply Chain considerations for a temperature sensitive product
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online